| Literature DB >> 23544020 |
Richard J Bransford1, Fangyi Zhang, Carlo Bellabarba, Michael J Lee.
Abstract
STUDYEntities:
Year: 2010 PMID: 23544020 PMCID: PMC3609007 DOI: 10.1055/s-0028-1100889
Source DB: PubMed Journal: Evid Based Spine Care J ISSN: 1663-7976
Fig. 1Patient sampling and selection flow chart
Demographic characteristics comparing treatment groups at study entry
| Posterior (N = 24) | Anterior (N = 10) | ||
|---|---|---|---|
| Age (years) | 50.4 (18–71) | 49.9 (35–57) | .92 |
| Male | 14 (58) | 7 (70) | .70 |
| BMI | 32 (24–47) | 28.8 (18–42) | .25 |
| T1–2 | 1 | 0 | .51 |
| T2–3 | 1 | 0 | .51 |
| T3–4 | 0 | 0 | 1.0 |
| T4–5 | 1 | 0 | .51 |
| T5–6 | 1 | 0 | .51 |
| T6–7 | 2 | 3 | .06 |
| T7–8 | 7 | 3 | .67 |
| T8–9 | 6 | 1 | .32 |
| T9–10 | 3 | 3 | .11 |
| T10–11 | 3 | 1 | .84 |
| T11–12 | 10 | 1 | .41 |
| Morbid obesity | 5 (21) | 2 (20) | 0.96 |
| Diabetes | 3 (13) | 2 (20) | 0.62 |
| COPD | 2 (8) | 2 (20) | 0.56 |
| Mean follow-up (weeks) | 41 (6–168) | 34 (6–112) | 0.65 |
Chronic obstructive pulmonary disease.
Immediate postoperative measures comparing treatment groups
| Posterior (N = 24) | Anterior (N = 10) | ||
|---|---|---|---|
| Measure | Mean ± SD | Mean ± SD | |
| EBL Total (cc) | 740 ± 812 | 691 ± 371 | .86 |
| EBL per level (cc) | 493 ± 524 | 633 ± 346 | .4 |
| Length of stay | 4.2 ± 2.0 | 7.3 ± 3.2 | <.003 |
Refer to online appendix for explanation of two patients excluded in LOS from posterior group.
Comparison of neurological and pain outcomes comparing treatment groups
| Pain (VAS score) | Neurological improvement (ASIA score) | |||
|---|---|---|---|---|
| Posterior | Anterior | Posterior | Anterior | |
| Baseline (points) | 6.9 (±3.2) | 6.7 (±1.4) | 87.4 (±9.9) | 92.1 (±3.9) |
| Follow-up (points) | 2.3 (± 2.0) | 4.3 (± 2.5) | 90.6 (± 11.3) | 95.5 (± 5.6) |
| Change (points) | 4.6 | 2.4 | 3.2 | 3.4 |
| Within group | <.0001 | .01 | .67 | .37 |
| Between group | .05 | .98 | ||
Neurology was compared in patients with a motor score less than 100 (N = 13). The remaining patients had motor scores of 100 preoperatively and at final follow-up.
P-value associated with change from baseline to 12 months within each treatment group.
P-value comparing baseline to 12 month changes between posterior and anterior approaches.
Comparison of complication rates between treatment groups
| Posterior | Anterior | ||
| Number of patients with complications | 7 (35) | 3 (30) | .96 |
| Infection | 5 (25) | 0 | .08 |
| Pneumonia | 0 | 1 (10) | .15 |
| Wrong level surgery | 0 | 1 (10) | .15 |
| Recurrence | 1 (5) | 0 | .47 |
| Pulmonary embolism | 0 | 1 (10) | .15 |
| Implant complication | 1 (5) | 0 | .47 |
Chi-square test.
One patient with an infection developed osteomyelitis leading to a fracture which required a revision fusion.
Pneumonia with 1.5 L effusion.
Fig. 2Preoperative CT myelogram in 46-year-old woman with large calcified T8–9 thoracic disc herniation and myelopathy who underwent posterior decompression. Fig 2a sagittal cut and Fig 2b axial cut.
Fig. 3aIntraoperative fluoroscopy images showing endplate shaver used to prepare the disc space for the graft and Fig. 3b intraoperative lateral showing placement of pedicle screws with T-PLIF allograft in disc space for patient presented in Fig 2.
Fig. 5Preoperative MRI of 56-year-old woman with T9–10 thoracic disc herniation and myelopathy who underwent an anterior decompression. Fig 5a sagittal cut and Fig 5b axial cut.
Table of published retrospective case series describing operative management of thoracic disc herniations
| Posterior | Year | N | Approach | Complications n (%) | Neuro deterioration N (%) | Class of evidence |
|---|---|---|---|---|---|---|
| Maiman | 1984 | 23 | Lateral extracavitary | 0 (0%) | 0 (0%) | |
| Simpson | 1993 | 21 | Costotransversectomy | 0 (0%) | 0 (0%) | |
| Le Roux | 1993 | 20 | Transpedicular | 1 (5%) | 0 (0%) | |
| Levi | 1999 | 35 | Transpedicular | 2 (5.7%) | 1 (2.9%) | |
| Bilsky | 2000 | 20 | Transpedicular | 3 (15%) | 0 (0%) | |
| Bransford | 2010 | 18 | Transfacet | 6 (33%) | 1 (5.5%) | |
| Otani | 1988 | 23 | Transthoracic | 0 (0%) | 0 (0%) | |
| Bohlman | 1988 | 19 | Transthoracic | 2 (11%) | 2 (11%) | |
| Fujimara | 1997 | 33 | Transthoracic | 2 (6%) | 0 (0%) | |
| Regan | 1998 | 29 | Video assisted | 4 (13.8%) | 0 (0%) | |
| Ayhan | 2010 | 27 | Transthoracic | 6 (21.4%) | 2 (7.4%) | |
| Stillerman | 1998 | 71 | 82 disc herniations | 12 (14.6%) | 1 (1.4%) | |
| 49 | Transthoracic | |||||
| 23 | Transfacet | |||||
| 8 | Lateral extracavitary | |||||
| 2 | Transpedicular |
Articles had to have a minimum of 15 patients in order to be included.
| Methods evaluation and class of evidence (CoE) | |
|---|---|
| Study design: | |
| Randomized controlled trial | |
| Cohort study | • |
| Case control | |
| Case series | |
| Statement of concealed allocation* | |
| Intent to treat* | |
| Independent or blind assessment | • |
| Complete follow-up of ≥85% | |
| Adequate sample size | |
| Controlling for possible confounding | |
| *Applies to randomized controlled trials only. | |